Study of XL999 in Patients With Previously Treated Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lynne A. Bui, MD
Exelixis
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Cancer Care, Inc.
Greenbrae, California, United States
- Hematology/oncology Associates of the Treasure Coast
Port Saint Lucie, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Joliet Oncology-Hematology Associates, Ltd
Joliet, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Harry and Jeanette Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Bradley Cohen
New City, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- 30 Nov 2006
- Completion
- 30 Nov 2006
- Last update posted
- 22 Feb 2010
- Registered enrollment
- 24
- Registry id
- NCT00277290
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.